NCT05010083 is a Phase 1, PHASE2 clinical trial of diet and lifestyle program in Obesity, sponsored by University of Michigan.

Who is sponsoring NCT05010083?

NCT05010083 is sponsored by University of Michigan.

What drugs are being tested in NCT05010083?

Interventions in NCT05010083: diet and lifestyle program.

Is NCT05010083 still recruiting?

NCT05010083 is currently completed. Last updated 24 October 2022.

Last reviewed 2022-10-24 · How we verify

NCT05010083

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The University of Michigan OWL (Online Wellness and Lifestyle) Study

Completed Phase 1, PHASE2 Last updated 24 October 2022

What this trial tests

Phase 1, PHASE2 trial testing diet and lifestyle program in Obesity in 17 participants. Completed in 1 June 2022.

Timeline

23 August 2021

Primary endpoint
1 June 2022

1 June 2022

Quick facts

Lead sponsor	University of Michigan
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	23 August 2021
Primary completion	1 June 2022
Estimated completion	1 June 2022
Sites	1 location across United States

Drugs / interventions tested

diet and lifestyle program

Conditions studied

Obesity — all drugs for Obesity →

Sponsor

University of Michigan

Who can join

Adults 18 to 25, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this trial is to pilot test our existing very low carbohydrate diet intervention, adapted for young adults.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility and acceptability of an online multicomponent very low-carbohydrate intervention in young adult women with obesity: a pilot study.
Saslow LR, O'Brien A, Raymond K, Bayandorian H, et al · · 2024 · cited 2× · PMID 39075617 · DOI 10.1186/s40814-024-01525-0

Verify or expand the search:

Other trials of diet and lifestyle program

Trials testing the same drug.

NCT05010070 — The University of Michigan Wellness for Liver Health Study · Phase 1, PHASE2 · completed
NCT03987854 — The University of Michigan PCOS Intervention Using Nutritional Ketosis · Phase 1, PHASE2 · completed
NCT03037528 — Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes · NA · completed

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05010083 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 24 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05010083.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing